How Researchers Used CRISPR Gene Editing to Send Immune Cells After Cancer

Last week, researchers published the results of a clinical trial that used CRISPR gene editing to create a large population of cancer-targeting immune cells. The trial was short, and the reprogrammed immune cells weren’t especially effective against the cancer. But the technology, or something similar, is likely to be used in additional attempts to attack cancer and potentially treat a variety of diseases. Read more…